We describe the case of a 45-year-old woman who had drawn our attention for some recent episodes of transient global amnesia that, upon further examination, resulted from ischemic events caused by multiple arterial thrombosis (bilateral internal carotid occlusion, significant stenosis of the right external carotid, mild stenosis of the right vertebral artery, right anterior cerebral artery occlusion and severe stenosis of the anterior descending coronary artery) due to primary antiphospholipid syndrome. Revascularisation of either carotid was not attempted. A percutaneous intervention in the anterior descending coronary artery stenosis was performed successfully. Due to severe arterial thrombosis, the patient was discharged with only duplex antiplatelet treatment and subcutaneous anticoagulant therapy, since immunotherapy is not indicated in primary APS. The occurrence of transient global amnesia should raise the suspicion of APS.
Antiphospholipid-antibody syndrome (APS)
is an autoimmune thrombophilic disorder that is considered primary when no underlying diseases occur and secondary when other diseases or therapy with medications are associated. The diagnosis of APS is correlated with the simultaneous presence of at least one clinical [vascular thrombosis (blood clots) in any organ or tissue or pregnancy event] and one laboratory criterion [persistently (6 weeks apart) positive antiphospholipid antibodies (lupus anticoagulant test, moderate-to-high titre anticardiolipin antibodies, or moderate-to-high titrẽ 2-g1ycoprotein-1 antibodies)] (1). Antiphospholipid antibodies comprise different antibody subgroups (lupus anticoagulants, anticardiolipin and anti-~2GPI antibodies) and have a prevalence of approximately 10% among healthy individuals in the general population (l). Although their clinical significance is unclear, these antibodies are associated with significant morbidity and mortality due to the development of thrombotic complications despite appropriate medical treatment (2) . Interestingly, clinical studies have demonstrated that lupus anticoagulants (LACs) increase the odds of stroke more than 40-fold and of myocardial infarction more than 5-fold in women under 50 years of age (3) . Indeed, LACs are directed against negatively charged phospholipid binding proteins, most often~2GPI and prothrombin (4) . According to a meta-analysis of 25 studies involving more than 7,000 patients, LACs are stronger risk factors for thrombosis than anticardiolipin antibodies during APS (5) .
Transient ischemic attack, schizophrenia-like symptoms, ocular involvement, neuroretinitis, headaches, migraines, oscillopsia, chorea, convulsions, myelopathy, Guillain-Barre syndrome, peripheral neuropathy and memory loss have been described as neurological manifestations of APS (6) (7) (8) (9) (10) (11) . In this report, we present a case in which transient global amnesia, the aetiology of which is connected to the insurgence ofischaemic events (12) , was the first clinical symptom of APS complicated by multiple arterial thromboses.
Case report
A 45-year-old woman, who had drawn our attention due to the appearance of transient global amnesia, was successively diagnosed with primary APS, marked by the presence of LACs, occlusion of both internal carotids and the right anterior cerebral artery, severe stenosis of the left anterior descending coronary artery, and significant and mild stenosis of the right external carotid and the right vertebral artery, respectively.
The patient reported that while driving home, she inadvertently arrived at a completely unknown place and immediately called her husband to take her home; she did not remember any other particular of that event but had reported two other similar episodes over the previous two months.
The past clinical history included pregnancy morbidity (two unexplained spontaneous foetal deaths) and compensated diabetes treated with subcutaneous insulin. She denied any cocaine or alcohol abuse presyncope, syncope, palpitations or chest pain but admitted to smoking ten cigarettes a day. The physical and neurologic examinations were normal (no headache, altered cognition, hemiparesis, aphasia, ataxia, any type of visual symptoms, oral ulcers or abdominal pain was observed; no purpura, livedo reticularis, myalgia, mono-or polyneuropathy or claudication of extremities appeared). Chest X-ray results (no nodules or fixed infiltrates) and urinalysis were normal (no proteinuria or hematuria). Laboratory data showed the absence of staining for the antineutrophilic cytoplasmic antibody (ANCA) and other autoantibodies such as anticardiolipin and anti-~2GPI; the biochemical parameters studied were also normal (haematological, renal, liver function and those of coagulation), except a prolonged partial thromboplastin time (1.5 times the mean prolonged partial thromboplastin time); no coagulation factor deficiency was present. Therefore, an LAC diagnosis was made based on phospholipid-sensitive functional clotting testing (diluted Russell's viper venom time) and was confirmed subsequently.
Colour Doppler sonography showed occlusion of both internal carotids, reverse flow in the ophthalmic arteries and significant stenosis of the right external carotid (reperfused, via reverse flow, by the right superior thyroid artery, in turn, supplied by the left superior thyroid artery) ( Fig. 1 ).
Magnetic resonance with contrast medium showed occlusion ofthe right anterior cerebral artery ( Fig. 2) and an area of cerebral ischemia near this artery. Selective arteriography showed mild ostial stenosis of the right vertebral artery, severe stenosis of the right external carotid artery ( Fig. 3 ), bilateral occlusion of the internal carotid and severe stenosis ofthe descending anterior coronary artery, which was successfully revascularised ( Fig. 4 A,B) . No vessel changes consistent with vasculitides (abdominal aneurysms, prominent dilations alternating with narrowing ofthe arteries in the intra-eerebral region) were present in the angiographic study. Vasculitides were also excluded basing on validated classification criteria approved by the European League Against Rheumatism, Paediatric Rheumatology International Trials Organisation, and Paediatric Rheumatology European Society (EULAR, PRINTO, PRES) as well as according to the criteria proposed by the American College of Rheumatology (ACR) and the Chapel Hill Consensus Conference nomenclature (13, 14) .
The patient was discharged on the third postoperative day in good general condition with a diagnosis of APS. The treatment regimen included dual antiplatelet (acetylsalicylic acid + clopidogrel) and subcutaneous anticoagulant therapy (enoxaparin 4000 I.U.lday).
A recent colour Doppler sonographic control confirmed occlusion of both internal carotids and patency of the collateral circulation (reverse flow in ophthalmic and right superior thyroid arteries). The patient denied new episodes of transient global
Fig. 1. Double panoramic colour Doppler sonographic view ofthe thyroid and vascular supply. A vascular anastomosis along the thyroid capsule is shown between the left superior thyroid and right superior thyroid arteries. In the right picture, theflow in the right superior thyroid artery displays a reversal in the direction offlow (the Doppler trace is below the baseline). In the left picture, the left superior thyroid artery displays a normal direction offlow and supplies the right superior thyroid artery (the Doppler trace is above the baseline).

Fig. 2. Intracranial enhanced angiographic MR reveals a non-enhancing right anterior cerebral artery.
amnesia or memory loss.
DISCUSSION
Our patient had no clinical, laboratory or diagnostic imaging findings suggestive of any vasculitis according to the classification criteria of the EULAR, PRINTO, PRES, and ACR as well as the Chapel Hill Consensus Conference nomenclature (13, 14) .
Indeed no signs of cutaneous, general or angiographic vasculitis were observed; however, multiple arterial thromboses were present in several vascular areas, which is consistent with the diagnosis ofAPS.
Interestingly, the only clinical manifestation for which the patient was admitted to the Hospital was the presence of transient global amnesia, which according to some authors, may be a neurological manifestation of ischaemic origin (12) . Transient global amnesia has previously been described in patients with antiphospholipid antibodies without relevant thrombotic abnormalities but not in patients with full-blown APS (15) (16) (17) . In our patient, transient global amnesia was the first clinical symptom of severe APS in which multiple arterial thromboses were present.
Interestingly, antiphospholipid antibodies can activate cerebral endothelium, thus promoting procoagulant actrvrty, and can bind to glial cells, myelin and neurons, which results in their deregulation (11) . Both of these mechanisms might have facilitated the development of multiple arterial thromboses in our patient.
Transient ischemic attack, stroke and myocardial infarction represent 2.3%, 2.4% and 0.9%, respectively, of clinical manifestations related to APS. In tum, stroke and myocardial infarction represent respectively 13.2% and 18.9%, cases of death due to APS (6) . Ocular manifestations have also been described in several patients with APS and neuroretinitis (7) .
Fortunately, the severe vascular complications our patient developed had not caused severe cerebral clinical consequences with the exception of some episodes of transient global amnesia. The vascular cerebral supply (through hypertrophied vertebral, basilar and posterior cerebral arteries and through the vascular anastomosis) assured sufficient brain perfusion to avoid transient ischemic attack or stroke, despite the mild right ostial vertebral artery stenosis and bilateral internal carotid occlusion.
We did not treat the ostial stenosis of the right vertebral artery, due to the conspicuous posterior cerebral flow, nor did we attempt revascularisation of either internal carotid.
Catastrophic APS, characterised by a diffuse thrombotic microvasculopathy involving parenchymal organs such as the heart, might be a further clinical evolution of APS in our patient. Myocardial infarction occurs as an initial sign of catastrophic APS in 25% of patients (18) . Therefore, revascularisation of the descending anterior coronary artery was strongly indicated in this case. This procedure was performed successfully.
We did not administer immunotherapy to reduce the level of antiphospholipid antibodies since this treatment is preferentially reserved to patients with certain catastrophic APS whereas it is not usually prescribed to primary APS patients (19) (20) (21) .
In accordance with other reports (17, (19) (20) (21) , because indefinite life-long anticoagulation therapy is essential to reduce the risk of recurrent thrombotic events (21) , and due to the stent implantation and to the fact that the target international normalised ratio (INR) could not be maintained using an oral anticoagulant, we associated duplex antiplatelet treatment with subcutaneous anticoagulation. Although recurrence is not unusual even with adequate medical treatment, our patient is enjoying good health one year and some months after the intervention. As previously observed by others (17) , after the initiation of anti-aggregation therapy, our patient had no further episodes of transient global amnesia or memory loss and colour Doppler sonography did not show any worsening in collateral vascular supply, confirming the adequacy of our therapeutic strategy.
The presence of antiphospholipid antibodies or of APS must be suspected in young patients whose first clinical manifestation is transient global amnesia. Prompt anti-aggregation therapy (and anticoagulation treatment if necessary) should be started.
